You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Technology Review reports some researchers are trying homemade SARS-CoV-2 vaccines on themselves.
In more than a dozen new papers, ENCODE researchers reported on analyses of the human and mouse genomes, using new data types and additional tissues.
The partners will use ReviveMed's AI-driven platform to better understand mechanisms of immunotherapy response and resistance in cancer patients.
The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.
The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.
In Genome Research this week: Y chromosome gene expression analysis, de novo mutations rise with paternal age in rhesus macaques, and more.
The Massachusetts Institute of Technology has ended its journal subscription contract negotiations with Elsevier.
A comparative genomics and machine-learning analysis spanning almost 1,000 viral genomes pointed to two proteins that appear to be altered in SARS-CoV-2 and MERS-CoV.
In Nature this week: genome-wide association study of 42 diseases among Japanese population, transfer RNA modifications, and more.
Using single-cell RNA sequencing, researchers identified cells in mouse and human prostate tissues that appear to help regrow the gland after prostate cancer treatment.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.